Main research strategy of Generi Biotech is focused on two research lines:

  • Anti-Bio-Terror Tools Line of Research (Development of detection systems for weapons of mass destruction and bioterrorism agents)
    Development of “anti-bio-terror” tools became a quite important field of research around the world, especially after the 11th of September 2001. Although bioterrorism agents have not been used anywhere, a potential threat of their misuse remains high. 

    According to Centers for Disease Control and Prevention (CDC), potential bioterrorism agents are divided into 3 categories, regarding to supposed damage if they are used either as bioterrorism agents or weapons of mass destruction.

    More about this line of research
     
  • Drug Discovery Line of Research
    Most of biotechnology and pharmaceutical companies are aware that it may not be economically efficient to maintain all R&D activities in-house. It seems that leading international pharma companies are gradually adopting outsourcing strategies in order to focus on their core activities and thus increase competitiveness. Outsourcing expenditures account now for about 25-30% of total operating costs and it is probable that hey will grow to 30-50% in the future.

    More about this line of research